Skip to main content

Advertisement

Log in

Long non-coding RNA UCA1 regulates MPP+-induced neuronal damage through the miR-671-5p/KPNA4 pathway in SK-N-SH cells

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Parkinson’s disease (PD) is an age-related neurodegenerative disease. Long non-coding RNA urothelial carcinoma-associated 1 (UCA1) is involved in the pathogenesis of PD. However, the pathogenesis of PD regulated by UCA1 has not been fully explained. We used 1-Methyl-4-phenylpyridinium (MPP+)-induced SK-N-SH cells for functional analysis. Expression levels of UCA1, microRNA (miR)-671-5p, and KPNA4 (karyopherin subunit alpha 4) mRNA were detected using quantitative real-time polymerase chain reaction (qRT-PCR). Cell viability and apoptosis were analyzed using MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) or flow cytometry assays. Some protein levels were measured by western blotting. The levels of pro-inflammatory cytokines were tested by ELISA (enzyme-linked immunosorbent assay). The levels of LDH (lactate dehydrogenase), MDA (malondialdehyde), and SOD (superoxide dismutase) were measured using corresponding kits. The relationship between UCA1 or KPNA4 and miR-671-5p was verified by dual-luciferase reporter assay and/or RNA immunoprecipitation (RIP) assay. MPP+ induced UCA1 expression in SK-N-SH cells in a concentration-dependent manner or time-dependent manner. UCA1 knockdown reduced MPP+-induced apoptosis, inflammation, and oxidative stress in SK-N-SH cells. MiR-671-5p was downregulated while KPNA4 was upregulated in MPP+-treated SK-N-SH cells. UCA1 sponged miR-671-5p to regulate KPNA4 expression. MiR-671-5p inhibition counteracted UCA1 knockdown-mediated influence on apoptosis, inflammation, and oxidative stress of MPP+-induced SK-N-SH cells. KPNA4 overexpression offset the inhibitory influence of miR-671-5p mimic on apoptosis, inflammation, and oxidative stress of MPP+-treated SK-N-SH cells. UCA1 inhibition reduced MPP+-induced neuronal damage through the miR-671-5p/KPNA4 pathway in SK-N-SH cells, providing a novel mechanism to understand the pathogenesis of PD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

Not applicable.

Code availability

Not applicable.

References

  • Cacabelos R (2017) Parkinson’s, Disease: From pathogenesis to pharmacogenomics. Int J Mol Sci 18(3):551

  • Cai L, Tu L, Li T, Yang X, Ren Y, Gu R, Zhang Q, Yao H, Qu X, Wang Q, Tian J (2019) Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson’s disease through the inhibition of the PI3K/Akt signaling pathway. Int Immunopharmacol 75:105734

    Article  CAS  PubMed  Google Scholar 

  • Cao Z, Pan X, Yang Y, Huang Y, Shen H-B (2018) The lncLocator: a subcellular localization predictor for long non-coding RNAs based on a stacked ensemble classifier. Bioinf (Oxford England) 34:2185–2194

    Article  CAS  Google Scholar 

  • Chen J, Zeng L, Xia T, Li S, Yan T, Wu S, Qiu G, Liu Z (2015) Toward a biomarker of oxidative stress: a fluorescent probe for exogenous and endogenous malondialdehyde in living cells. Anal Chem 87:8052–8056

    Article  CAS  PubMed  Google Scholar 

  • Corti O, Lesage S, Brice A (2011) What genetics tells us about the causes and mechanisms of Parkinson’s disease. Physiol Rev 91:1161–1218

  • Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson’s disease. J Parkinsons Dis 3:461–491

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fagerlund R, Kinnunen L, Köhler M, Julkunen I, Melén (2005) K NF-{kappa}B is transported into the nucleus by importin {alpha}3 and importin {alpha}4. J Biol Chem 280:15942–15951

    Article  CAS  PubMed  Google Scholar 

  • Francelle L, Galvan L, Gaillard M-C, Petit F, Bernay B, Guillermier M, Bonvento G, Dufour N, Elalouf J-M, Hantraye P, Déglon N, de Chaldée M (2015) Brouillet E Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo. Neurobiol Aging 36:1601.e1607-1601.1616

    Article  Google Scholar 

  • Gao H-M, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ, Lee VMY (2008) Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J Neurosci: Off J Soc Neurosci 28:7687–7698

    Article  CAS  Google Scholar 

  • Ghosh A, Tyson T, George S, Hildebrandt EN, Steiner JA, Madaj Z, Schulz E, Machiela E, McDonald WG, Escobar Galvis ML, Kordower JH, Van Raamsdonk JM, Colca JR (2016) Brundin P Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson’s disease. Sci Transl Med 8:368ra174

    Article  PubMed  Google Scholar 

  • Gonçalves AP, Máximo V, Lima J, Singh KK, Soares P, Videira A (2011) Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone. Biochim Biophys Acta 1813:492–499

    Article  PubMed  PubMed Central  Google Scholar 

  • Hauser DN, Hastings TG (2013) Mitochondrial dysfunction and oxidative stress in Parkinson’s disease and monogenic parkinsonism. Neurobiol Dis 51:35–42

    Article  CAS  PubMed  Google Scholar 

  • Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol 8:382–397

    Article  CAS  PubMed  Google Scholar 

  • Hu X, Ma R, Fu W, Zhang C, Du X (2019) LncRNA UCA1 sponges miR-206 to exacerbate oxidative stress and apoptosis induced by ox-LDL in human macrophages. J Cell Physiol 234:14154–14160

    Article  CAS  PubMed  Google Scholar 

  • Li X, Diao H, Circular (2019) RNA circ_0001946 acts as a competing endogenous RNA to inhibit glioblastoma progression by modulating miR-671-5p and CDR1. J Cell Physiol 234:13807–13819

  • Lin Q, Hou S, Dai Y, Jiang N, Lin Y (2019) LncRNA HOTAIR targets miR-126-5p to promote the progression of Parkinson’s disease through RAB3IP. Biol Chem 400:1217–1228

    Article  CAS  PubMed  Google Scholar 

  • Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego, Calif) 25:402–408

  • Lu M, Sun WL, Shen J, Wei M, Chen B, Qi YJ, Xu CS (2018) LncRNA-UCA1 promotes PD development by upregulating SNCA. Eur Rev Med Pharmacol Sci 22:7908–7915

    CAS  PubMed  Google Scholar 

  • Marchenko ND, Hanel W, Li D, Becker K, Reich N, Moll UM (2010) Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-alpha3 binding. Cell Death Differ 17:255–267

    Article  CAS  PubMed  Google Scholar 

  • Nakamori M, Junn E, Mochizuki H, Mouradian MM (2019) Nucleic acid-based therapeutics for Parkinson’s disease. Neurotherapeutics 16:287–298

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nan A, Chen L, Zhang N, Liu Z, Yang T, Wang Z, Yang C (2017) Jiang Y A novel regulatory network among LncRpa, CircRar1, MiR-671 and apoptotic genes promotes lead-induced neuronal cell apoptosis. Arch Toxicol 91:1671–1684

    Article  CAS  PubMed  Google Scholar 

  • Ping X, Cheng Y, Bao J, Shi K, Zou J, Shentu X (2021) KPNA4 is involved in cataract formation via the nuclear import of p53. Gene 786:145621

    Article  CAS  PubMed  Google Scholar 

  • Rashid F, Shah A, Shan G (2016) Long non-coding RNAs in the cytoplasm. Genom Proteom Bioinform 14:73–80

    Article  Google Scholar 

  • Salmena L, Poliseno L, Tay Y, Kats L (2011) Pandolfi PP A ceRNA hypothesis: the Rosetta Stone of a hidden RNA. language? Cell 146:353–358

    Article  CAS  PubMed  Google Scholar 

  • Savitt JM, Dawson VL, Dawson TM (2006) Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Investig 116:1744–1754

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shi CH, Huang Y, Li WQ, Chen RG (2019) Influence of LncRNA UCA1 on glucose metabolism in rats with diabetic nephropathy through PI3K-Akt signaling pathway. Eur Rev Med Pharmacol Sci 23:10058–10064

    PubMed  Google Scholar 

  • Song H, Xu Y, Xu T, Fan R, Jiang T, Cao M, Shi L, Song J (2020) CircPIP5K1A activates KRT80 and PI3K/AKT pathway to promote gastric cancer development through sponging miR-671-5p. J Cell Physiol 126:109941

    CAS  Google Scholar 

  • Subramaniam SR, Chesselet M-F (2013) Mitochondrial dysfunction and oxidative stress in Parkinson’s disease. Prog Neurobiol 106–107:17–32

    Article  PubMed  Google Scholar 

  • Sun S-C (2017) The non-canonical NF-κB pathway in immunity and inflammation. Nat Rev Immunol 17:545–558

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tansey MG, Goldberg MS (2010) Neuroinflammation in Parkinson’s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 37:510–518

    Article  CAS  PubMed  Google Scholar 

  • Thomson DW, Dinger ME (2016) Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet 17:272–283

    Article  CAS  PubMed  Google Scholar 

  • Uwatoko H, Hama Y, Iwata IT, Shirai S, Matsushima M, Yabe I, Utsumi J, Sasaki H (2019) Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson’s disease. Mol Brain 12:49

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang D-Q, Fu P, Yao C, Zhu L-S, Hou T-Y, Chen J-G, Lu Y, Liu D, Zhu L-Q (2018) Long non-coding RNAs, novel culprits, or bodyguards in neurodegenerative diseases. Mol Ther Nucleic Acids 10:269–276

    Article  CAS  PubMed  Google Scholar 

  • Wang X-S, Zhang Z, Wang H-C, Cai J-L, Xu Q-W, Li M-Q, Chen Y-C, Qian X-P, Lu T-J, Yu L-Z, Zhang Y, Xin D-Q, Na Y-Q, Chen W-F (2006) Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res 12:4851–4858

    Article  CAS  PubMed  Google Scholar 

  • Xie X-X, Kou S-T, Pu Z-H, Hou C-Y, Tian Y-P (2007) Effects of scalp catgut embedding on SOD, NO, MDA in the rat with Parkinson’s disease. Zhongguo Zhen Jiu = Chin Acupuncture & Moxibustion 27:753–756

    CAS  Google Scholar 

  • Xing R-X, Li L-G, Liu X-W, Tian B-X, Cheng Y (2020) Down regulation of miR-218, miR-124, and miR-144 relates to Parkinson’s disease via activating NF-κB signaling. Kaohsiung J Med Sci 36:786–792

    Article  CAS  PubMed  Google Scholar 

  • Xu Z, Cawthon D, McCastlain KA, Duhart HM, Newport GD, Fang H, Patterson TA, Slikker W Jr (2005) Ali SF Selective alterations of transcription factors in MPP+-induced neurotoxicity in PC12 cells. Neurotoxicology 26:729–737

    Article  CAS  PubMed  Google Scholar 

  • Xue M, Chen W, Li X (2016) Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer. J Cancer Res Clin Oncol 142:1407–1419

    Article  PubMed  Google Scholar 

  • Yi J, Chen B, Yao X, Lei Y, Ou F, Huang F (2019) Upregulation of the lncRNA MEG3 improves cognitive impairment, alleviates neuronal damage, and inhibits activation of astrocytes in hippocampus tissues in Alzheimer’s disease through inactivating the PI3K/Akt signaling pathway. J Cell Biochem 120:18053–18065

    Article  CAS  PubMed  Google Scholar 

  • Zella MAS, Metzdorf J, Ostendorf F, Maass F, Muhlack S, Gold R, Haghikia A, Tönges L (2019) Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s disease. Cells 8(2):105

Download references

Author information

Authors and Affiliations

Authors

Contributions

Zhengheng Hao designed and performed the research; Wen Dang, Qingfeng Zhu, Jianxing Xu analyzed the data; Zhengheng Hao wrote the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Qingfeng Zhu.

Ethics declarations

Ethics approval and consent to participate

Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of the Second Hospital of Shanxi Medical University.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Fig. 1

(A) Protein levels of p-p65 and p65 in SK-N-SH cells at different groups (Control, MMP+, MMP++miR-NC, MMP++miR-671-5p, MMP++miR-671-5p + vector, or MMP++miR-671-5p + KPNA4) were detected. (C) The viability of SK-N-SH cells treated with different concentrations of MPP+ (0, 0.5, 1, 2, 4 mM) was determined. (C) Transfection efficiencies of three siRNAs were evaluated. *P < 0.05. (PNG 320 KB)

High Resolution Image (TIF 839 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hao, Z., Dang, W., Zhu, Q. et al. Long non-coding RNA UCA1 regulates MPP+-induced neuronal damage through the miR-671-5p/KPNA4 pathway in SK-N-SH cells. Metab Brain Dis 38, 961–972 (2023). https://doi.org/10.1007/s11011-022-01118-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-022-01118-x

Keywords

Navigation